StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)

Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%

Johnson & Johnson EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Johnson & Johnson's EV/EBITDA was 26.6× on Nov 11, 2026, against 13.3× a year earlier. Over the last 5 years it ranged from 11.1× to 26.6×, with a median of 17.0×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202626.6×+13.3
2025Dec 31, 202513.3×−1.0
2024Dec 31, 202414.3×−4.4
2023Dec 29, 202318.6×−0.9
2022Dec 30, 202219.6×+2.7
2021Dec 31, 202116.9×+0.7
2020Dec 31, 202016.2×−0.9
2019Dec 31, 201917.1×+2.8
2018Dec 31, 201814.3×−1.8
2017Dec 29, 201716.1×+3.0
2016Dec 30, 201613.0×+0.9
2015Dec 31, 201512.2×+0.4
2014Dec 31, 201411.8×−0.8
2013Dec 31, 201312.6×+0.2
2012Dec 31, 201212.4×+3.4
2011Dec 30, 20119.0×+0.7
2010Dec 31, 20108.3×−0.7
2009Dec 31, 20099.0×–

More Johnson & Johnson figures

See a number that looks wrong?